Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GABA_A receptor alpha6beta3delta subtype is a specific heteropentameric ligand-gated ion channel primarily located extrasynaptically in the cerebellar granule cells and trigeminal ganglia. Unlike the more common synaptic GABA_A receptors that mediate phasic inhibition, this subtype is responsible for tonic inhibition, providing a persistent inhibitory current that regulates the baseline excitability of neurons and enhances the signal-to-noise ratio in sensory processing. It is structurally distinct due to the presence of the alpha6 and delta subunits, which render it insensitive to classical benzodiazepines like diazepam but highly sensitive to neurosteroids and specific agonists like gaboxadol. This receptor subtype plays a significant role in motor control and sensory transmission, making it a promising therapeutic target for neurological conditions such as essential tremor, tinnitus, and trigeminal neuralgia. Research into selective positive allosteric modulators of this subtype aims to provide relief for these disorders without the sedative and cognitive side effects associated with non-selective GABAergic drugs.
Positive allosteric modulation or direct activation of the chloride ion channel, leading to increased chloride influx, neuronal hyperpolarization, and enhanced tonic inhibition.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha6beta3delta subtype (α6β3δ GABA_A receptor).